Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism

被引：1
|
作者：
Prasertpan, Tittaya [1 ,2 ]
Teeyapun, Nattaya [3 ,4 ]
Bhidayasiri, Roongroj [1 ,2 ,5 ]
Sringean, Jirada [1 ,2 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Chulalongkorn Ctr Excellence Parkinsons Dis & Rela, Bangkok, Thailand
[2] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
[3] Chulalongkorn Univ, Fac Med, Dept Med, Div Med Oncol, Bangkok, Thailand
[4] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[5] Royal Soc Thailand, Acad Sci, Bangkok, Thailand
来源：
MOVEMENT DISORDERS CLINICAL PRACTICE | 2023年 / 10卷
关键词：
immune checkpoint inhibitor; striatal encephalitis; Atezolizumab; neurotoxicity; parkinsonism;
D O I：
10.1002/mdc3.13800
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S7 / S11
页数：5
相关论文
共 50 条
  • [41] Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
    Ramayya, Tarun
    Mitchell, Joshua D.
    Hartupee, Justin C.
    Lavine, Kory
    Ridley, Clare H.
    Kotkar, Kunal D.
    Jimenez, Jesus
    Lin, Chieh-Yu
    Alvarez-Cardona, Jose A.
    Krone, Ronald K.
    Campbell, Courtney M.
    JACC: CARDIOONCOLOGY, 2022, 4 (05): : 722 - 726
  • [42] This month in JAAD Case Reports: April 2023: Immune checkpoint inhibitor-associated novel cutaneous eruptions
    Sloan, Brett
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (04) : 788 - 788
  • [43] Immune checkpoint inhibitor-associated Vogt-Koyanagi-Harada-like syndrome: A descriptive systematic review
    Huixin Anna Zhang
    Amelia T. Yuan
    Noémie Chiasson
    Kevin Y. Wu
    Ananda Kalevar
    Journal of Ophthalmic Inflammation and Infection, 15 (1)
  • [44] Cardiac magnetic resonance-based layer-specific strain in immune checkpoint inhibitor-associated myocarditis
    Li, Zheng
    Zhao, Rui
    Wang, Cong
    Wang, Yan
    Lin, Jinyi
    Zhao, Shihai
    Chen, Jiahui
    Zhou, Yuhong
    Liu, Tianshu
    Wang, Feng
    Shu, Xianhong
    Zeng, Mengsu
    Cheng, Leilei
    ESC HEART FAILURE, 2024, 11 (02): : 1061 - 1075
  • [45] Peripheral biomarkers to assess risk, severity, and prognosis of immune checkpoint inhibitor-associated myocarditis: a retrospective clinical study
    Guan, Zhengkun
    Yao, Tiezhu
    Liu, Guang
    Liu, Jing
    Guo, Ling
    Li, Zhenli
    Ma, Jingtao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [46] Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor
    Robert, Lucie
    Langner-Lemercier, Sophie
    Angibaud, Alexis
    Sale, Alexandre
    Thepault, Fanny
    Corre, Romain
    Lena, Herve
    Ricordel, Charles
    CLINICAL LUNG CANCER, 2020, 21 (05) : E474 - E477
  • [47] Soluble biomarkers for immune checkpoint inhibitor-related encephalitis: A mini-review
    Farina, A.
    Villagran-Garcia, M.
    Joubert, B.
    REVUE NEUROLOGIQUE, 2024, 180 (09) : 982 - 988
  • [48] Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates
    Singh, Shailbala
    Clemente, Leticia C.
    Parra, Edwin R.
    Tchakarov, Amanda
    Yang, Chao
    Li, Yisheng
    Long, James P.
    Yee, Cassian
    Lin, Jamie S.
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [49] Pneumotoxicity associated with immune checkpoint inhibitor therapies
    Shannon, Vickie R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (04) : 305 - 316
  • [50] Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis
    Mosaferi, Tina
    Tsai, Karen
    Sovich, Samantha
    Wilhalme, Holly
    Kathuria-Prakash, Nikhita
    Praw, Stephanie S.
    Drakaki, Alexandra
    Angell, Trevor E.
    Lechner, Melissa G.
    THYROID, 2022, 32 (05) : 496 - 504
12345